Galimedix Therapeutics

Novel Treatment for Neurodegenerative Diseases of the Eye and Brain

Active Seed Startup Shorashim Founded 2017-06

Website ↗ LinkedIn

Galimedix is a Phase 2 clinical-stage company developing novel oral and topical neuroprotective therapies with the potential to revolutionize the treatment of serious eye and brain diseases. Galimedix’s groundbreaking small molecules offer the hope of changing the course of disease where amyloid beta plays a role, such as in dry AMD, glaucoma and Alzheimer’…